Health and Medicine
Jul. 12, 2012—An experimental drug that activates T-cells and promotes an immune response to fight tumors has shown promising early results in patients with kidney cancer, melanoma and non-small cell lung cancer. Vanderbilt-Ingram Cancer Center investigators Leora Horn, M.D., Jeffrey Sosman, M.D., and researchers from several other cancer centers tested the new compound. The results of the...
Jul. 12, 2012—A genetic variant may help keep an individual’s “good” cholesterol in check.
Jul. 3, 2012—Obesity increases the risk of acute kidney injury following cardiac surgery, according to a Vanderbilt study published in the Journal of the American Society of Nephrology.
Jun. 28, 2012—Intensive care units at Vanderbilt University Hospital and the Monroe Carell Jr. Children’s Hospital at Vanderbilt are achieving exceptionally low rates of central line-associated blood stream infection (CLABSI), according to a report released this week by the Tennessee Department of Health.
Jun. 15, 2012—Nonsupportive family members contribute to poor adherence to medication regimens and lower glycemic control in adults with diabetes.